tiprankstipranks
Trending News
More News >
Sleep Number Corp (SNBR)
:SNBR
Advertisement

Sleep Number (SNBR) AI Stock Analysis

Compare
443 Followers

Top Page

SNBR

Sleep Number

(NASDAQ:SNBR)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 4o)
Rating:39Underperform
Price Target:
$4.00
▼(-37.21% Downside)
Sleep Number's overall stock score is primarily impacted by its poor financial performance and challenging valuation metrics. The technical analysis also indicates bearish trends. While strategic initiatives are underway, the current financial health and market conditions present significant risks.
Positive Factors
Cost Reduction Achievements
Significant cost reductions enhance operational efficiency and can improve profitability, providing a stronger financial foundation for future growth.
Bank Agreement Extension
The extended bank agreement provides financial flexibility, allowing the company to focus on strategic initiatives and long-term growth.
Marketing Efficiency Improvements
Improved marketing efficiency can lead to increased customer acquisition and revenue growth, strengthening market position.
Negative Factors
Declining Revenue
A significant decline in revenue indicates challenges in maintaining market share and could impact long-term financial stability.
Negative Profitability
Negative profitability reflects operational inefficiencies and financial strain, potentially hindering investment in growth opportunities.
High Leverage
High leverage increases financial risk and limits the company's ability to invest in strategic initiatives, affecting long-term growth prospects.

Sleep Number (SNBR) vs. SPDR S&P 500 ETF (SPY)

Sleep Number Business Overview & Revenue Model

Company DescriptionSleep Number Corporation (SNBR) is a leading retailer of sleep solutions, specializing in innovative adjustable air mattresses and sleep-related products. Founded in 1987, the company operates predominantly in the home furnishings sector, offering a diverse range of products that include mattresses, bases, bedding accessories, and sleep tracking technology. Sleep Number is recognized for its commitment to enhancing sleep quality through personalized sleep experiences, leveraging advanced technology in their products to cater to individual preferences and needs.
How the Company Makes MoneySleep Number generates revenue primarily through the sale of its customizable mattresses and related sleep products. The company's revenue model is centered around direct-to-consumer sales through its extensive network of retail stores and its e-commerce platform. Key revenue streams include the sale of mattresses, adjustable bases, bedding accessories, and smart sleep technology systems. Additionally, Sleep Number benefits from recurring revenue through the sale of replacement parts and accessories for their products. The company has also established partnerships with various health and wellness organizations to promote the importance of sleep health, which can drive brand awareness and customer loyalty, further contributing to its earnings.

Sleep Number Earnings Call Summary

Earnings Call Date:Sep 27, 2025
(Q3-2025)
|
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant financial restructuring and cost reduction efforts, which are expected to support future growth. However, the company's current financial performance, including a notable decline in sales and profits, reflects ongoing challenges in the competitive landscape.
Q3-2025 Updates
Positive Updates
Bank Agreement Extension
Secured an amendment and extension of the bank agreement through 2027, providing financial flexibility to focus on sales-driving initiatives and execute the turnaround strategy.
Cost Reduction Achievements
Reduced operating expenses, excluding restructuring and nonrecurring costs, by $115 million with an expectation to exceed the $130 million cost-out target for 2025.
Marketing Efficiency Improvements
Achieved a 6% decline in cost per acquisition versus the prior year, with improvements in marketing efficiency expected to drive increased traffic in the future.
Negative Updates
Q3 Revenue Decline
Net sales of $343 million were down 19.6% year-over-year, driven by reduced marketing and media investments and increased competition.
Profit and Cash Flow Below Expectations
Profits and cash flow were well below expectations, resulting in a reduction of full year net sales, adjusted EBITDA, and free cash flow expectations.
Gross Profit Margin Decline
Gross profit margin was 59.9%, down 93 basis points versus last year, mainly due to unit volume deleverage.
Restructuring and Nonrecurring Costs
Recorded $41 million in restructuring and other nonrecurring costs in Q3, with significant noncash charges related to asset impairments.
Company Guidance
During the Q3 2025 earnings call, Sleep Number provided guidance that emphasized a strategic turnaround aimed at stabilizing and growing sales in 2026. The company reported a 19.6% decline in Q3 net sales to $343 million, with a gross profit margin of 59.9%. Operating expenses, excluding restructuring costs, fell by 18% year-over-year to $204 million. Despite a challenging competitive environment and media spend reductions of 32% in Q2 and Q3, Sleep Number is optimistic about future prospects. They secured an amendment to their bank agreement through 2027, allowing for increased financial flexibility to invest in growth initiatives. The company expects full-year 2025 net sales of approximately $1.4 billion, with adjusted EBITDA of around $70 million and a negative free cash flow of approximately $50 million. Looking ahead, Sleep Number plans to simplify its product offerings, enhance marketing strategies, optimize its distribution model, and continue cost reduction efforts, including a focus on real estate consolidation, to drive improved financial performance in 2026.

Sleep Number Financial Statement Overview

Summary
Sleep Number faces significant financial challenges, including declining revenues, negative profitability, high financial leverage, and cash flow difficulties. The income statement, balance sheet, and cash flow analysis all indicate a need for strategic improvements to stabilize operations.
Income Statement
45
Neutral
Sleep Number's income statement reveals a challenging period with declining revenue and profitability. The TTM data shows a negative net profit margin of -2.66% and a gross profit margin of 60.05%, indicating pressure on profitability. Revenue has decreased by 5.49% compared to the previous period, reflecting a downward trend. The EBIT and EBITDA margins are also negative, highlighting operational challenges. Overall, the income statement reflects a need for strategic improvements to reverse the declining trend.
Balance Sheet
30
Negative
The balance sheet shows significant financial leverage with a negative stockholders' equity, resulting in a concerning debt-to-equity ratio. The TTM data indicates a debt-to-equity ratio of -0.69, suggesting high financial risk. Return on equity is positive at 8.03%, but the negative equity position poses a risk to financial stability. The equity ratio is not calculable due to negative equity, underscoring the need for capital restructuring.
Cash Flow
40
Negative
Cash flow analysis reveals substantial challenges with negative operating and free cash flows in the TTM period. The free cash flow growth rate is positive at 268.83%, but this is from a negative base, indicating volatility. The operating cash flow to net income ratio is negative, reflecting cash flow difficulties. The free cash flow to net income ratio is 1.63, suggesting some ability to cover net losses with free cash flow, but overall cash flow stability is a concern.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.44B1.68B1.89B2.11B2.18B1.86B
Gross Profit865.25M1.00B1.09B1.20B1.32B1.16B
EBITDA22.84M89.22M95.34M135.28M253.93M246.46M
Net Income-78.11M-20.33M-15.29M36.61M153.75M139.19M
Balance Sheet
Total Assets749.39M860.81M950.88M953.94M919.54M800.14M
Cash, Cash Equivalents and Short-Term Investments1.26M1.95M2.54M1.79M2.39M4.24M
Total Debt940.71M936.11M972.65M896.01M791.05M589.36M
Total Liabilities1.27B1.31B1.39B1.39B1.34B1.02B
Stockholders Equity-521.34M-451.59M-441.93M-438.18M-424.95M-223.98M
Cash Flow
Free Cash Flow-49.98M3.64M-66.08M-33.32M233.11M240.59M
Operating Cash Flow-28.52M27.14M-9.03M36.14M300.01M279.66M
Investing Cash Flow-21.45M-26.29M-58.35M-70.61M-66.64M-39.02M
Financing Cash Flow49.65M-1.44M68.13M33.87M-235.22M-237.99M

Sleep Number Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price6.37
Price Trends
50DMA
5.88
Negative
100DMA
7.48
Negative
200DMA
8.04
Negative
Market Momentum
MACD
-0.53
Negative
RSI
47.36
Neutral
STOCH
74.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNBR, the sentiment is Neutral. The current price of 6.37 is above the 20-day moving average (MA) of 4.48, above the 50-day MA of 5.88, and below the 200-day MA of 8.04, indicating a neutral trend. The MACD of -0.53 indicates Negative momentum. The RSI at 47.36 is Neutral, neither overbought nor oversold. The STOCH value of 74.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SNBR.

Sleep Number Risk Analysis

Sleep Number disclosed 2 risk factors in its most recent earnings report. Sleep Number reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Sleep Number Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$1.63B18.238.82%2.97%1.78%-25.36%
66
Neutral
$614.02M13.079.96%7.65%-4.61%-25.66%
66
Neutral
$1.21B5.5526.20%2.29%-6.03%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
55
Neutral
$1.09B-1.18%4.74%5.37%-127.27%
48
Neutral
$87.51M-1.03-9999.00%-9.47%48.11%
39
Underperform
$95.95M-16.95%-88.00%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SNBR
Sleep Number
5.10
-10.57
-67.45%
ETD
Ethan Allen
23.64
-5.49
-18.85%
MLKN
MillerKnoll
15.92
-9.24
-36.72%
LZB
La-Z-Boy Incorporated
39.52
-5.25
-11.73%
LEG
Leggett & Platt
10.14
-2.34
-18.75%
PRPL
Purple Innovation
0.79
-0.19
-19.39%

Sleep Number Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Sleep Number Secures Credit Agreement Extension
Positive
Nov 10, 2025

Sleep Number Corporation announced on November 5, 2025, that it has secured an amendment and extension of its credit agreement through 2027, which aligns with its planned turnaround strategy. This updated agreement, reflecting increased covenant levels and expanded addbacks, demonstrates lender confidence and provides financial flexibility, supporting the company’s expectation to comply with new covenants and generate meaningful free cash flow in 2026.

The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.

Executive/Board ChangesPrivate Placements and Financing
Sleep Number Amends Credit Agreement, Extends Maturity Date
Neutral
Nov 5, 2025

On November 4, 2025, Sleep Number Corporation executed a Twelfth Amendment to its Credit and Security Agreement, extending the maturity date to December 3, 2027, and adjusting various financial covenants and credit facilities. This amendment signifies a strategic financial restructuring for the company, ensuring compliance with all covenants and facilitating the retirement of Board member Stephen L. Gulis, Jr., who stepped down following the amendment’s qualification as a debt refinancing.

The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 26, 2025